Technology
OMRON Corporation(OMRNY)
Live Price
Offline$37.70
+3.46% today
1Y Change
+27.96%
Window
Jun 26, 2025 โ Jun 16, 2026
- Market Cap
- $1.10T
- Revenue Growth
- -2.1%
- EPS Growth
- +100.7%
- Dividend Yield
- 1.9%
Coverage: 244 bars ยท Jun 26, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
OMRON Corporation (OMRNY) is a Technology stock with a market cap of $1.10T and listed on OTC. The stock last traded around $37.70 and up 28.0% across the available one-year price window (Jun 26, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of -2.1%, EPS growth of +100.7%, a dividend yield of 1.9%. What stands out right now is revenue -2.1%, EPS +100.7%, free cash flow +1450.1% with operating margin 6.2% and ROIC 2.5%. The dividend is present but secondary, with a yield around 1.9%. Valuation already assumes a fairly strong business story at P/E 46.9 and price/sales 1.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines OMRNY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-2.1% vs +11.9% peer median
Operating Margin
Below sector median
+6.2% vs +22.0% peer median
P/E
Above sector median
46.9 vs 18.5 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 14, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -2.1% and EPS is at +100.7%, with operating margin around 6.2%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 1.9%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +3.1% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 14, 2026 | โ | -3.3% | -8.7% | -8.1% |
2026 Feb 5, 2026 | -52.8% | +17.0% | +22.3% | +19.0% |
2025 Nov 7, 2025 | -53.8% | -5.9% | -4.5% | -2.1% |
Benchmark Edge
OMRNY vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
OMRNY
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
OMRNY Max Drawdown
-24.93%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for OMRNY and SPY.
Company Overview
OMRON Corporation
Other OTC
OMRON Corporation engages in industrial automation, electronic and mechanical components, social systems, and healthcare businesses worldwide. The company's Industrial Automation Business offers sensors, switches, safety and control components, relays, automation systems, motion/drives, robotics, energy conservation support/environment measure equipment, and power supplies. Its Electronic and Mechanical Components Business provides relays, switches, connectors, sensors, and components/units for amusement equipment. The company's Social Systems, Solutions and Service Business offers terminals and systems, including PV inverters and storage batteries; railway station systems, such as automated ticket gates and ticket vending machines, traffic and road management systems, payment systems, and UPS that protect equipment from unexpected power disruption; a range of solutions comprising software development and maintenance services to support the social infrastructure; and transport management systems and infrastructure monitoring systems. Its Healthcare Business offers blood pressure monitors; nebulizers; electrotherapy TENS devices; digital thermometers; body composition monitors; and other products, such as activity monitors, AEDs, etc. OMRON Corporation has an agreement with JMDC Inc. to jointly develop personalized aggravation and nursing care prevention solutions that support prescription medication treatments and patient lifestyle changes by predicting the risk of the onset of individual patient events. The company was formerly known as OMRON Tateisi Electronics Co. and changed its name to OMRON Corporation in January 1990. OMRON Corporation was founded in 1933 and is headquartered in Kyoto, Japan.
- Leadership
- Junta Tsujinaga
- IPO Date
- Feb 27, 1996
- Employees
- 28.4k
- Street Address
- Shiokoji Horikawa
- Mailing
- Kyoto, 600-8530
- Region
- Kyoto, JP
- Reporting Currency
- USD
- Investor Line
- 81 75 344 7000
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 46.9
- EV/EBITDA
- 13.7
- Price/Sales
- 1.3
- Price/Book
- 1.4
Growth
- Revenue
- -2.1%
- EPS
- +100.7%
- Free Cash Flow
- +1450.1%
Profitability
- Gross Margin
- 43.6%
- Operating Margin
- 6.2%
- Net Margin
- 2.8%
- ROE
- 3.0%
- ROIC
- 2.5%
Balance Sheet
- Debt/Equity
- 0.28
- Current Ratio
- 2.11
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.